SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Company Shanghai Shyndec Pharmaceutical Co., Ltd.

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2024-12-12			5-day change	1st Jan Change
12.69 ^CNY	+2.34%		+5.14%	+29.62%

06:44am	Shyndec Pharmaceutical Unit Gets Nod to Register Cefpodoxime Proxetil Tablets	MT
Dec. 06	Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials	MT

Business description: Shanghai Shyndec Pharmaceutical Co., Ltd.

SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Number of employees: 11,608

Sales by Activity: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceuticals Segment	12.2B	12.56B	13.94B	12.96B	12.07B

See all business segments

Geographical breakdown of sales: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2019	2020	2021	2022	2023
East China	3.6B	3.4B	3.69B	3.68B	3.17B
Overseas	2.05B	2.3B	2.84B	2.49B	2.47B
North China	1.27B	1.61B	1.71B	1.75B	1.4B
Southern China	1.57B	1.43B	1.57B	1.2B	1.28B
South-West China	1.24B	1.31B	1.47B	1.48B	1.26B
Central China	1.14B	1.25B	1.25B	1.17B	1.13B
North-West China	625M	561M	564M	541M	573M
North-East China	561M	540M	669M	502M	514M

See all geographic segments

Managers: Shanghai Shyndec Pharmaceutical Co., Ltd.

Director	Title	Age	Since
Qian Yin Jing IRC	Investor Relations Contact	44	2019-09-12
Zhong Xi Zhang SEC	Corporate Secretary	48	2024-03-27

See SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. governance

Members of the board: Shanghai Shyndec Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Xiang Dong Yu BRD	Director/Board Member	60	2019-01-30
Peng Wang BRD	Director/Board Member	42	2022-11-27
Yong Liu BRD	Director/Board Member	55	2021-05-16
Shu Yuan Wei BRD	Director/Board Member	60	2020-05-28
Ru Li BRD	Director/Board Member	45	2022-11-27
Fan Hong Wu BRD	Director/Board Member	56	2019-02-12
Kan Tian BRD	Director/Board Member	61	2019-02-12
Ying Qi Li BRD	Director/Board Member	48	2022-11-27
Yong Gang Xing CHM	Chairman	48	2019-11-24
Yong Hua Zuo BRD	Director/Board Member	48	2022-11-27

Composition of the Board of Directors

Shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.

Name	Equities	%	Valuation
China State-Owned Assets Supervision & Admn Commission 30.83 %	413,518,181	30.83 %	696 M ¥
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. 12.46 %	167,142,202	12.46 %	281 M ¥
SINOPHARM GROUP CO. LTD. 1.422 %	19,068,440	1.422 %	32 M ¥
Yan Lin Han 1.292 %	17,326,019	1.292 %	29 M ¥
Shandong State-Owned Asset Sup. & Adm. Commission 1.181 %	15,834,626	1.181 %	27 M ¥

Name	Equities	%	Valuation
China State-Owned Assets Supervision & Admn Commission 100.00 %	145,102,781	100.00 %	244 M ¥

List of SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. shareholders

Company details: Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai Shyndec Pharmaceutical Co., Ltd.

378 Jianlu Road Pudong New Area

200137, Shanghai

+86 21 6251 0990

http://www.shyndec.com

address Shanghai Shyndec Pharmaceutical Co., Ltd.(600420)

Specialty & Advanced Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+2.34%	+5.14%	+24.90%	+34.57%	2.29B
MERCK KGAA	-0.73%	+2.29%	+4.03%	-36.91%	65.74B
KYOWA KIRIN CO. LTD.	-0.30%	+0.47%	+0.14%	-23.35%	8.22B
YUHAN CORPORATION	+0.26%	-0.85%	+87.68%	+113.45%	6.11B
HALOZYME THERAPEUTICS, INC.	+1.50%	+0.33%	+19.83%	+39.12%	6.03B
SK BIOPHARMACEUTICALS CO., LTD.	+6.28%	+2.04%	+17.71%	-1.41%	5.41B
BETTA PHARMACEUTICALS CO., LTD.	+1.35%	-1.24%	-5.19%	-33.30%	3.11B
SUPERNUS PHARMACEUTICALS, INC.	-1.02%	-1.50%	+37.13%	+30.12%	2.03B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+1.70%	+2.09%	-33.76%	+30.37%	2.02B
VELOXIS PHARMACEUTICALS A/S	-.--%	-.--%	-	-	1.64B
Average	+1.14%	+0.35%	+16.94%	+16.96%	10.26B
Weighted average by Cap.	+0.06%	+1.56%	+10.55%	-15.84%